Buscar
BioVie Inc
BIVIAñadir a la lista de seguimiento
1.950USD
-0.230-10.55%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
14.71MCap. mercado
PérdidaP/E TTM
Más Datos de BioVie Inc Compañía
BioVie Inc. is a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. In neurodegenerative disease, the Company's drug candidate bezisterim inhibits inflammatory activation of extracellular signal-regulated kinase and the transcription factor nuclear factor-kB, and the associated neuroinflammation and insulin resistance, but not ERK and NFkB homeostatic functions (such as insulin signaling and neuron growth and survival). Both neuroinflammation and insulin resistance are drivers of Alzheimer’s disease (AD) and Parkinson’s disease (PD). Persistent systematic inflammation and neuroinflammation are key features in patients with neurological symptoms of long COVID. In liver disease, the Company's orphan drug candidate BIV201, is being evaluated for Phase III clinical testing for the reduction of further decompensation in participants with liver cirrhosis and ascites.
Información de BioVie Inc
Símbolo de cotizaciónBIVI
Nombre de la empresaBioVie Inc
Fecha de salida a bolsaJan 14, 2014
Director ejecutivoDo (Viet Cuong Viet)
Número de empleados13
Tipo de seguridadOrdinary Share
Fin del año fiscalJan 14
Dirección680 W Nye Lane
CiudadCARSON CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal89703
Teléfono17758883162
Sitio Webhttps://www.bioviepharma.com/
Símbolo de cotizaciónBIVI
Fecha de salida a bolsaJan 14, 2014
Director ejecutivoDo (Viet Cuong Viet)
Ejecutivos de BioVie Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Joseph M. Palumbo, M.D.
Dr. Joseph M. Palumbo, M.D.
Chief Medical Officer
Chief Medical Officer
1.19K
+8.38%
Ms. Joanne Wendy Kim, CPA
Ms. Joanne Wendy Kim, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
941.00
+10.63%
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Chairman of the Board
Independent Chairman of the Board
690.00
+0.14%
Mr. Michael Edward Sherman, J.D.
Mr. Michael Edward Sherman, J.D.
Independent Director
Independent Director
208.00
--
Mr. Sigmund (Sig) Rogich
Mr. Sigmund (Sig) Rogich
Independent Director
Independent Director
--
--
Mr. Viet Cuong Do
Mr. Viet Cuong Do
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Amy S. Chappell, M.D.
Dr. Amy S. Chappell, M.D.
Independent Director
Independent Director
--
--
Mr. Kameel D. Farag
Mr. Kameel D. Farag
Independent Director
Independent Director
--
--
Mr. Bruce Mackle
Mr. Bruce Mackle
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Joseph M. Palumbo, M.D.
Dr. Joseph M. Palumbo, M.D.
Chief Medical Officer
Chief Medical Officer
1.19K
+8.38%
Ms. Joanne Wendy Kim, CPA
Ms. Joanne Wendy Kim, CPA
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
941.00
+10.63%
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Chairman of the Board
Independent Chairman of the Board
690.00
+0.14%
Mr. Michael Edward Sherman, J.D.
Mr. Michael Edward Sherman, J.D.
Independent Director
Independent Director
208.00
--
Mr. Sigmund (Sig) Rogich
Mr. Sigmund (Sig) Rogich
Independent Director
Independent Director
--
--
Mr. Viet Cuong Do
Mr. Viet Cuong Do
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de BioVie Inc?
Los cinco principales accionistas de BioVie Inc son: Dr. Joseph M. Palumbo, M.D.
¿Cuántas instituciones poseen acciones de BioVie Inc (BIVI)?
A fecha de 2026Q1, 125 instituciones poseen acciones de BioVie Inc, con un valor de mercado combinado de aproximadamente 1.18M, lo que representa el 15.63% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -357412.00.